Join our distributor network

Join our distributor network

As a reference for healthcare professionals since 2005 in France in the field of rheumatology LABRHA is now ready to develop its activity across the globe and become a major actor internationally. In order to achieve this challenge, we are looking to expand our distributor network to provide practitioners and...
About LABRHA

About LABRHA

Founded by Patrick Sac-Epée in 2005 in the city of Lyon in France, LABRHA is dedicated to the conception and development of natural products in rheumatology. OUR MISSION LABRHA’s mission is to meet patients’ and practitioners’ needs helping them to find, in the management of rheumatic diseases and musculoskeletal pains,...
New intra-articular injections combining HA + Mannitol

New intra-articular injections combining HA + Mannitol

LABRHA offers today a complete range of new and innovative viscosupplements, each one having its own characteristics and specific indications. With LABRHA’s viscoelastic solutions, you can treat all type of joints (including small and medium-sized joints) and adapt treatment depending on the severity of the disease (from grade I to...
Focus on quality and efficacy with strong work on basic and clinical research

Focus on quality and efficacy with strong work on basic and clinical research

Experimental studies and clinical trials are endlessly conducted on our products. All experimental studies and clinical trials to date have shown significant results. Several of them have been published in international peer-reviewed scientific journals. LABRHA also displays each year several scientific posters at different congresses Viscosupplements: HAPPYVISC (ongoing) Randomized, prospective,...
Cope with Fibromyalgia thanks to LABRHA's natural products for fibromyalgia sufferers

Cope with Fibromyalgia thanks to LABRHA’s natural products for fibromyalgia sufferers

LESS PAIN AND FATIGUE AND MORE ENERGY: COPE WITH FIBROMYALGIA THANKS TO FIBROMYALGINE® & FIBROMYALGINE® FORTE! Fibromyalgia is one of the most common chronic pain condition. It affects an estimated 2% of world population. Fibromyalgia is about seven times more common in women than men, and is more likely to...
AINAT®: First natural anti-inflammatory product

AINAT®: First natural anti-inflammatory product

Risk of adverse effects of classic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): AINAT®: Natural and well tolerated solution with anti-inflammatory action Thanks to its exclusive formulation combining 3 traditional medicinal plants with anti-inflammatory properties acting in total synergy , Ainat™ helps reduce muscle and joint discomfort and improves mobility and quality of...
NUTROS®: Discover the first intelligent Calcium/Vitamin D to promote bone health

NUTROS®: Discover the first intelligent Calcium/Vitamin D to promote bone health

Calcium bioavailability: inulin content of Nutros® makes the difference! Beyond adequate Calcium intake, Calcium bioavailability is also an important parameter to keep bones strong and healthy. Calcium is the most common and abundant mineral in the human body. It is a structural component of bones, teeth, and soft tissues and...
Look after your joints and improve your quality of life with LABRHA's natural products for joint health

Look after your joints and improve your quality of life with LABRHA’s natural products for joint health

Understanding joints A joint is where two bones meet. Joints hold the bones together and allow our rigid skeleton to move and be flexible. Cartilage is a hard, smooth tissue that covers the end of bones. Between the cartilage of two bones which form a joint, there is a small...
Keep your body on move: Discover LABRHA's range of products for tendon health

Keep your body on move: Discover LABRHA’s range of products for tendon health

EVERY MOVE YOU MAKE IS DEPENDENT ON YOUR TENDONS Tendons are strong connective tissues that connect muscles to bones and allow movement. Every move you make is then dependent on your tendons, on their health and strength. However, tendons are regularly prone to injuries resulting in pain, inflammation and weakening...
Latest entries
LABRHA at the SFR Congress in Paris in December 2017

LABRHA at the SFR Congress in Paris in December 2017

LABRHA took part in the 30th annual Congress of the French Society of Rheumatology (SFR) which took place last 10th to 12th of December in Paris. During this congress LABRHA presented its latest scientific works in 2 oral communication presentations and 2 posters. ORAL COMMUNICATIONS 1 // Influence of the radiological grade on viscosupplementation response...
LABRHA at the ISIAT Congress in Prague in October 2017

LABRHA at the ISIAT Congress in Prague in October 2017

The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), this congress is, as its name suggests, focus on intra-articular management of joint disease including intra-articular access, therapeutic targets and...
4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

2017 was no exception and after 3 successful editions, LABRHA organised last 07th and 08th of September 2017  its 4th LABRHA European Board on Viscosupplementation. 8 members of the EUROVISCO group participated this year. The group welcomed for this edition a new participant from Turkey, Prof. Demirhan Diracoglu, Physical Medicine and Rehabilitation specialist at the...
Viscosupplementation in the knee: 80% responders at 6 months with a single intra-articular injection of HAppyCross®

Viscosupplementation in the knee: 80% responders at 6 months with a single intra-articular injection of HAppyCross®

Results of an international study conducted in patients with knee OA A Franco-British work has been recently published in the Journal CARTILAGE(1) and presented at the 4th edition of the International Symposium on Intra-articular Treatment (ISIAT), which took place last 5th to 7th of October 2017. This work analysed the percentage of “responders”, 6 months...
Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Is the addition of a polyol to hyaluronic acid a significant advance in the treatment of osteoarthritis? Conrozier T. Curr Rheumatol Rev. 2017 Jul 10. doi:10.2174/1573397113666170710115558. Viscosupplementation with intra-articular injections of hyaluronic acid is recommended as a second line treatment for knee OA, after failure of non-pharmacological modalities and usual pain killers. Nevertheless there is...